AREC

American Resources (AREC)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AREC
DataOraFonteTitoloSimboloCompagnia
09/05/202413:00GlobeNewswire Inc.Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump deliveryNASDAQ:ARECAmerican Resources Corporation
12/03/202412:30GlobeNewswire Inc.ARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITYNASDAQ:ARECAmerican Resources Corporation
05/03/202414:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARECAmerican Resources Corporation
17/11/202308:00GlobeNewswire Inc.First Product Incorporating Arecor’s Arestat Technology, At220, Launched in EuropeNASDAQ:ARECAmerican Resources Corporation
28/08/202312:09Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ARECAmerican Resources Corporation
17/08/202300:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARECAmerican Resources Corporation
14/08/202322:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARECAmerican Resources Corporation
20/07/202313:00GlobeNewswire Inc.Arecor: Business UpdateNASDAQ:ARECAmerican Resources Corporation
28/06/202314:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARECAmerican Resources Corporation
16/06/202315:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARECAmerican Resources Corporation
08/06/202322:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARECAmerican Resources Corporation
23/05/202323:04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ARECAmerican Resources Corporation
15/05/202322:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARECAmerican Resources Corporation
01/05/202322:32Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:ARECAmerican Resources Corporation
10/02/202323:02Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ARECAmerican Resources Corporation
08/02/202319:50Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ARECAmerican Resources Corporation
01/11/202207:00Business WireTetris Pharma Launches Ogluo® in GermanyNASDAQ:ARECAmerican Resources Corporation
01/11/202207:00Business WireTetris Pharma bringt Ogluo® in Deutschland auf den MarktNASDAQ:ARECAmerican Resources Corporation
26/10/202223:25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on American Resources (AREC)NASDAQ:ARECAmerican Resources Corporation
11/10/202213:00GlobeNewswire Inc.Headline results from Phase I clinical trial of ultra-rapid acting insulin candidate AT247 demonstrate significantly accelerated insulin absorption and early exposure compared to gold standard insulins NovoLog® and Fiasp®NASDAQ:ARECAmerican Resources Corporation
09/10/202217:30ValueWalkThese Were The Five Best And Worst Performing Energy Stocks In Q3 2022NASDAQ:ARECAmerican Resources Corporation
17/08/202212:15TipRanksH.C. Wainwright Keeps Their Buy Rating on American Resources (AREC)NASDAQ:ARECAmerican Resources Corporation
25/07/202212:16TipRanksAmerican Resources (AREC) Gets a Buy Rating from H.C. WainwrightNASDAQ:ARECAmerican Resources Corporation
14/07/202213:00GlobeNewswire Inc.BUSINESS UPDATENASDAQ:ARECAmerican Resources Corporation
18/05/202213:00GlobeNewswire Inc.ARECOR TO HOST KOL WEBINAR ON THE NEED FOR CONCENTRATED AND RAPID ACTING INSULIN TREATMENTS IN DIABETES CARENASDAQ:ARECAmerican Resources Corporation
16/05/202214:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARECAmerican Resources Corporation
28/04/202213:54InvestorsHub NewsWireAmerican Resources Corporation Secures Worldwide Rights to New Provisional Patent for Producing Battery-Grade Lithium, Cobalt and NickelNASDAQ:ARECAmerican Resources Corporation
28/04/202213:00GlobeNewswire Inc.ARECOR PRESENTS FULL DATA FROM POSITIVE PHASE I CLINICAL TRIAL OF AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN FOR DIABETES AT ATTD MEETINGNASDAQ:ARECAmerican Resources Corporation
12/04/202213:00GlobeNewswire Inc.Arecor Announces Oral Presentation at Attd 2022 of Phase i Clinical Trial of At278 Ultra-Concentrated Ultra-Rapid Acting Insulin for DiabetesNASDAQ:ARECAmerican Resources Corporation
31/03/202212:16TipRanksH.C. Wainwright Sticks to Their Buy Rating for American Resources (AREC)NASDAQ:ARECAmerican Resources Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AREC
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network